Antibody Drug Conjugates Market Worth to cross USD 16.13 billion By 2027
Posted On September 17, 2021
The Global Antibody Drug Conjugates Market value is expected to grow by an impressive 26% of CAGR during the forecast period of 2021 to 2027. The market can grow to USD 16.13 billion by 2027 as per the report by Value Market Research. The increasing number of patients suffering from cancer across the world along with rising consumption of tobacco and alcohol is driving the demand of ADCs. Also, food and drug administration (FDA) approval to the companies for antibody-drug conjugates is further fuelling the market growth. In addition, the growing collaborations between research institutes and biotechnology and biopharmaceutical companies are also expected to boost the market growth in upcoming years. Whereas, the high cost of procedures and lack of fund is anticipated to limit the market growth.
Antibody-drug conjugates or ADCs are amalgamate of antibody specific to the target associated antigen, a cytotoxic agent to kill cancer cells and a chemical linker to attach the cytotoxic agent to the antibody. ADCs are designed to kill only cancer cells without harming the other cells. Its general principle is to target a particular cell population.
The detailed research study "Global Antibody Drug Conjugates Market Report By Types (Monoclonal Antibodies, Linker, Drug/Toxin, Others) By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumour, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" assists in understanding the market dynamics with qualitative as well as quantitative data.
On the basis of types the market is segmented into Monoclonal Antibodies, Linker, Drug/Toxin, Others. By application the antibody drug conjugates market is categorised as Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumour, Others. The regions covered in the market study are North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. This section throws light on the geographical spread of revenue and/or volume of the antibody drug conjugates market.
The Report Segments Global Antibody Drug Conjugates Market -
- Monoclonal Antibodies
- Blood Cancer
- Breast Cancer
- Ovarian Cancer
- Lung Cancer
- Brain Tumour
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Players Profiled In the Report:
F. Hoffman-La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Seattle Genetics Inc., Genentech Inc., Immunogen Inc., Immunomedics, Inc., Progenics Pharmaceuticals Inc., and Bayer Healthcare Pharmaceuticals
Download the FREE SAMPLE of Global Antibody Drug Conjugates Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]